Location History:
- Gentilly, FR (2002 - 2005)
- Nouviotou, FR (2007)
Company Filing History:
Years Active: 2002-2007
Title: Michel Samson: Innovator in HIV Research
Introduction
Michel Samson is a prominent inventor based in Gentilly, France. He has made significant contributions to the field of biomedical research, particularly in the area of HIV treatment. With a total of five patents to his name, Samson's work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
Among his latest patents, Samson has developed screening methods for identifying compounds that decrease HIV entry into a cell. This innovation involves a peptide with an amino acid sequence that has more than 80% homology with the amino acid sequence listed as SEQ ID NO:4. Additionally, a nucleic acid molecule has been identified that shows more than 80% homology with one of the nucleic acid sequences listed as SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3. Furthermore, ligands, anti-ligands, and cell vectors related to the peptide and/or nucleic acid molecule are also utilized in this research. Another significant patent involves CCR5 chemokine receptor-specific antibodies, which similarly utilize peptides and nucleic acid molecules with high homology to those previously mentioned.
Career Highlights
Michel Samson is currently associated with Euroscreen S.A., a company dedicated to advancing research in the field of drug discovery and development. His work at Euroscreen has allowed him to focus on innovative solutions for combating HIV and other diseases.
Collaborations
Samson has collaborated with notable colleagues in his field, including Marc Parmentier and Gilbert Vassart. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Michel Samson's contributions to HIV research through his innovative patents and collaborations highlight his commitment to improving healthcare outcomes. His work continues to pave the way for advancements in the treatment of HIV, showcasing the importance of innovation in the medical field.